Loading…

Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway

Ceramide, a key molecule in the metabolism of sphingolipids, is converted by ceramidase to sphingosine, and phosphorylated by ceramide kinase to form ceramide-1-phosphate (C1P). In this study, we improved on a method of thin-layer chromatography using a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Pharmacological Sciences 2010, Vol.114(4), pp.420-432
Main Authors: Tada, Eiko, Toyomura, Kaori, Nakamura, Hiroyuki, Sasaki, Hirotsune, Saito, Takeshi, Kaneko, Masayuki, Okuma, Yasunobu, Murayama, Toshihiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03
cites cdi_FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03
container_end_page 432
container_issue 4
container_start_page 420
container_title Journal of Pharmacological Sciences
container_volume 114
creator Tada, Eiko
Toyomura, Kaori
Nakamura, Hiroyuki
Sasaki, Hirotsune
Saito, Takeshi
Kaneko, Masayuki
Okuma, Yasunobu
Murayama, Toshihiko
description Ceramide, a key molecule in the metabolism of sphingolipids, is converted by ceramidase to sphingosine, and phosphorylated by ceramide kinase to form ceramide-1-phosphate (C1P). In this study, we improved on a method of thin-layer chromatography using a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole–labeled C6-ceramide (NBD-ceramide) by adding another step for separation of extracted ceramide metabolites by lipophilicity, and determined levels of C1P, caproic acid, sphingomyelin, and glucosylceramide simultaneously. Also we found that 1) treatment of NBD-ceramide–labeled cells (human lung adenocarcinoma A549 cells and Chinese hamster ovary cells) with Na3VO4 increased the amount of NBD-C1P formed within 30 min, 2) the treatment increased production of NBD-caproic acid, a counterpart of sphingosine, by ceramidase within 2 h, 3) expression of ceramide kinase enhanced the Na3VO4-induced formation of NBD-C1P, and tyrosine kinase inhibitors (herbimycin and genistein) decreased the response, 4) the production of NBD-caproic acid in A549 cells was inhibited by genistein, and 5) the responses for 2 h after Na3VO4 treatment were accompanied by a decrease in the production of NBD-sphingomyelin, not a loss of NBD-ceramide. The improved thin-layer chromatography method was useful for the simultaneous determination of enzymatic activities for ceramide metabolism in cells.
doi_str_mv 10.1254/jphs.10181FP
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1750bccab989434593a4ff4bd6cc1f3e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319308205</els_id><doaj_id>oai_doaj_org_article_1750bccab989434593a4ff4bd6cc1f3e</doaj_id><sourcerecordid>818642591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03</originalsourceid><addsrcrecordid>eNptUcFy0zAQ9TAwtBRunBnfuJCya8m2fOyktHQoQw-Fq2YtrRtlHDtITpjc-Af-kC9BiROfuEha7Zu3b99LkrcIl5jl8uNyvQiXCKjw5uFZco5CljNVSPV8eqM4S16FsATIFGDxMjnLELNSqOo8oSszuC0Nru_Svknn7GnlLAVOqbOnktMvrtv_1bv0B3VkaeB06yil9HHn--C6E-Lv7z9f2brYt-kDDYtftHudvGioDfzmeF8k328-Pc4_z-6_3d7Nr-5nplTZMMtrMFJEsZUoKimhkLmArKpzSaSsRUUFGVAlVLkRwlTAja3ZIDV5SU0N4iK5G3ltT0u99m5Ffqd7cvrw0fsnTX5wpmWNZQ61MVRXqpJC5pUg2TSytoUx2AiOXO9HrrXvf244DHrlguG2pY77TdAKo8NZXmFEfhiRJvoQPDfTZAS9z0fv89HHfCL83ZF4U6_YTuBTIBFwOwJi1xlq-66N7uplv_FddE-bpgjGcacziAMAUYLUAEqDzGItRYYQd1J7Zdcj0zIM9MTTqJMJoy6UWh7Oo8KpbRbkNXeRphhpOGa3dez1Yb6J8jybIZrr_r_qPygNzYM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818642591</pqid></control><display><type>article</type><title>Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway</title><source>ScienceDirect</source><creator>Tada, Eiko ; Toyomura, Kaori ; Nakamura, Hiroyuki ; Sasaki, Hirotsune ; Saito, Takeshi ; Kaneko, Masayuki ; Okuma, Yasunobu ; Murayama, Toshihiko</creator><creatorcontrib>Tada, Eiko ; Toyomura, Kaori ; Nakamura, Hiroyuki ; Sasaki, Hirotsune ; Saito, Takeshi ; Kaneko, Masayuki ; Okuma, Yasunobu ; Murayama, Toshihiko ; Department of Health Science ; Department of Pharmacology ; Hokkaido University School of Medicine ; Laboratory of Chemical Pharmacology ; Graduate School of Pharmaceutical Sciences ; Chiba University ; Faculty of Pharmaceutical Sciences ; Chiba Institute of Science</creatorcontrib><description>Ceramide, a key molecule in the metabolism of sphingolipids, is converted by ceramidase to sphingosine, and phosphorylated by ceramide kinase to form ceramide-1-phosphate (C1P). In this study, we improved on a method of thin-layer chromatography using a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole–labeled C6-ceramide (NBD-ceramide) by adding another step for separation of extracted ceramide metabolites by lipophilicity, and determined levels of C1P, caproic acid, sphingomyelin, and glucosylceramide simultaneously. Also we found that 1) treatment of NBD-ceramide–labeled cells (human lung adenocarcinoma A549 cells and Chinese hamster ovary cells) with Na3VO4 increased the amount of NBD-C1P formed within 30 min, 2) the treatment increased production of NBD-caproic acid, a counterpart of sphingosine, by ceramidase within 2 h, 3) expression of ceramide kinase enhanced the Na3VO4-induced formation of NBD-C1P, and tyrosine kinase inhibitors (herbimycin and genistein) decreased the response, 4) the production of NBD-caproic acid in A549 cells was inhibited by genistein, and 5) the responses for 2 h after Na3VO4 treatment were accompanied by a decrease in the production of NBD-sphingomyelin, not a loss of NBD-ceramide. The improved thin-layer chromatography method was useful for the simultaneous determination of enzymatic activities for ceramide metabolism in cells.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.10181FP</identifier><identifier>PMID: 21127389</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>A549 and Chinese hamster ovary (CHO) cells ; Animals ; Cells, Cultured ; ceramidase ; Ceramidases - physiology ; ceramide kinase ; ceramide-1-phosphate ; Ceramides - analysis ; Ceramides - metabolism ; CHO Cells - metabolism ; Chromatography, Thin Layer - methods ; Cricetinae ; Cricetulus ; Humans ; Phosphorylation ; Phosphotransferases (Alcohol Group Acceptor) - physiology ; Protein-Tyrosine Kinases - physiology ; Sphingosine - analysis ; Stimulation, Chemical ; Tumor Cells, Cultured ; vanadate ; Vanadates - pharmacology</subject><ispartof>Journal of Pharmacological Sciences, 2010, Vol.114(4), pp.420-432</ispartof><rights>2010 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03</citedby><cites>FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319308205$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,4010,27900,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21127389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tada, Eiko</creatorcontrib><creatorcontrib>Toyomura, Kaori</creatorcontrib><creatorcontrib>Nakamura, Hiroyuki</creatorcontrib><creatorcontrib>Sasaki, Hirotsune</creatorcontrib><creatorcontrib>Saito, Takeshi</creatorcontrib><creatorcontrib>Kaneko, Masayuki</creatorcontrib><creatorcontrib>Okuma, Yasunobu</creatorcontrib><creatorcontrib>Murayama, Toshihiko</creatorcontrib><creatorcontrib>Department of Health Science</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Hokkaido University School of Medicine</creatorcontrib><creatorcontrib>Laboratory of Chemical Pharmacology</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Chiba University</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Chiba Institute of Science</creatorcontrib><title>Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>Ceramide, a key molecule in the metabolism of sphingolipids, is converted by ceramidase to sphingosine, and phosphorylated by ceramide kinase to form ceramide-1-phosphate (C1P). In this study, we improved on a method of thin-layer chromatography using a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole–labeled C6-ceramide (NBD-ceramide) by adding another step for separation of extracted ceramide metabolites by lipophilicity, and determined levels of C1P, caproic acid, sphingomyelin, and glucosylceramide simultaneously. Also we found that 1) treatment of NBD-ceramide–labeled cells (human lung adenocarcinoma A549 cells and Chinese hamster ovary cells) with Na3VO4 increased the amount of NBD-C1P formed within 30 min, 2) the treatment increased production of NBD-caproic acid, a counterpart of sphingosine, by ceramidase within 2 h, 3) expression of ceramide kinase enhanced the Na3VO4-induced formation of NBD-C1P, and tyrosine kinase inhibitors (herbimycin and genistein) decreased the response, 4) the production of NBD-caproic acid in A549 cells was inhibited by genistein, and 5) the responses for 2 h after Na3VO4 treatment were accompanied by a decrease in the production of NBD-sphingomyelin, not a loss of NBD-ceramide. The improved thin-layer chromatography method was useful for the simultaneous determination of enzymatic activities for ceramide metabolism in cells.</description><subject>A549 and Chinese hamster ovary (CHO) cells</subject><subject>Animals</subject><subject>Cells, Cultured</subject><subject>ceramidase</subject><subject>Ceramidases - physiology</subject><subject>ceramide kinase</subject><subject>ceramide-1-phosphate</subject><subject>Ceramides - analysis</subject><subject>Ceramides - metabolism</subject><subject>CHO Cells - metabolism</subject><subject>Chromatography, Thin Layer - methods</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Humans</subject><subject>Phosphorylation</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - physiology</subject><subject>Protein-Tyrosine Kinases - physiology</subject><subject>Sphingosine - analysis</subject><subject>Stimulation, Chemical</subject><subject>Tumor Cells, Cultured</subject><subject>vanadate</subject><subject>Vanadates - pharmacology</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUcFy0zAQ9TAwtBRunBnfuJCya8m2fOyktHQoQw-Fq2YtrRtlHDtITpjc-Af-kC9BiROfuEha7Zu3b99LkrcIl5jl8uNyvQiXCKjw5uFZco5CljNVSPV8eqM4S16FsATIFGDxMjnLELNSqOo8oSszuC0Nru_Svknn7GnlLAVOqbOnktMvrtv_1bv0B3VkaeB06yil9HHn--C6E-Lv7z9f2brYt-kDDYtftHudvGioDfzmeF8k328-Pc4_z-6_3d7Nr-5nplTZMMtrMFJEsZUoKimhkLmArKpzSaSsRUUFGVAlVLkRwlTAja3ZIDV5SU0N4iK5G3ltT0u99m5Ffqd7cvrw0fsnTX5wpmWNZQ61MVRXqpJC5pUg2TSytoUx2AiOXO9HrrXvf244DHrlguG2pY77TdAKo8NZXmFEfhiRJvoQPDfTZAS9z0fv89HHfCL83ZF4U6_YTuBTIBFwOwJi1xlq-66N7uplv_FddE-bpgjGcacziAMAUYLUAEqDzGItRYYQd1J7Zdcj0zIM9MTTqJMJoy6UWh7Oo8KpbRbkNXeRphhpOGa3dez1Yb6J8jybIZrr_r_qPygNzYM</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Tada, Eiko</creator><creator>Toyomura, Kaori</creator><creator>Nakamura, Hiroyuki</creator><creator>Sasaki, Hirotsune</creator><creator>Saito, Takeshi</creator><creator>Kaneko, Masayuki</creator><creator>Okuma, Yasunobu</creator><creator>Murayama, Toshihiko</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2010</creationdate><title>Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway</title><author>Tada, Eiko ; Toyomura, Kaori ; Nakamura, Hiroyuki ; Sasaki, Hirotsune ; Saito, Takeshi ; Kaneko, Masayuki ; Okuma, Yasunobu ; Murayama, Toshihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>A549 and Chinese hamster ovary (CHO) cells</topic><topic>Animals</topic><topic>Cells, Cultured</topic><topic>ceramidase</topic><topic>Ceramidases - physiology</topic><topic>ceramide kinase</topic><topic>ceramide-1-phosphate</topic><topic>Ceramides - analysis</topic><topic>Ceramides - metabolism</topic><topic>CHO Cells - metabolism</topic><topic>Chromatography, Thin Layer - methods</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Humans</topic><topic>Phosphorylation</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - physiology</topic><topic>Protein-Tyrosine Kinases - physiology</topic><topic>Sphingosine - analysis</topic><topic>Stimulation, Chemical</topic><topic>Tumor Cells, Cultured</topic><topic>vanadate</topic><topic>Vanadates - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tada, Eiko</creatorcontrib><creatorcontrib>Toyomura, Kaori</creatorcontrib><creatorcontrib>Nakamura, Hiroyuki</creatorcontrib><creatorcontrib>Sasaki, Hirotsune</creatorcontrib><creatorcontrib>Saito, Takeshi</creatorcontrib><creatorcontrib>Kaneko, Masayuki</creatorcontrib><creatorcontrib>Okuma, Yasunobu</creatorcontrib><creatorcontrib>Murayama, Toshihiko</creatorcontrib><creatorcontrib>Department of Health Science</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Hokkaido University School of Medicine</creatorcontrib><creatorcontrib>Laboratory of Chemical Pharmacology</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Chiba University</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Chiba Institute of Science</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tada, Eiko</au><au>Toyomura, Kaori</au><au>Nakamura, Hiroyuki</au><au>Sasaki, Hirotsune</au><au>Saito, Takeshi</au><au>Kaneko, Masayuki</au><au>Okuma, Yasunobu</au><au>Murayama, Toshihiko</au><aucorp>Department of Health Science</aucorp><aucorp>Department of Pharmacology</aucorp><aucorp>Hokkaido University School of Medicine</aucorp><aucorp>Laboratory of Chemical Pharmacology</aucorp><aucorp>Graduate School of Pharmaceutical Sciences</aucorp><aucorp>Chiba University</aucorp><aucorp>Faculty of Pharmaceutical Sciences</aucorp><aucorp>Chiba Institute of Science</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2010</date><risdate>2010</risdate><volume>114</volume><issue>4</issue><spage>420</spage><epage>432</epage><pages>420-432</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>Ceramide, a key molecule in the metabolism of sphingolipids, is converted by ceramidase to sphingosine, and phosphorylated by ceramide kinase to form ceramide-1-phosphate (C1P). In this study, we improved on a method of thin-layer chromatography using a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole–labeled C6-ceramide (NBD-ceramide) by adding another step for separation of extracted ceramide metabolites by lipophilicity, and determined levels of C1P, caproic acid, sphingomyelin, and glucosylceramide simultaneously. Also we found that 1) treatment of NBD-ceramide–labeled cells (human lung adenocarcinoma A549 cells and Chinese hamster ovary cells) with Na3VO4 increased the amount of NBD-C1P formed within 30 min, 2) the treatment increased production of NBD-caproic acid, a counterpart of sphingosine, by ceramidase within 2 h, 3) expression of ceramide kinase enhanced the Na3VO4-induced formation of NBD-C1P, and tyrosine kinase inhibitors (herbimycin and genistein) decreased the response, 4) the production of NBD-caproic acid in A549 cells was inhibited by genistein, and 5) the responses for 2 h after Na3VO4 treatment were accompanied by a decrease in the production of NBD-sphingomyelin, not a loss of NBD-ceramide. The improved thin-layer chromatography method was useful for the simultaneous determination of enzymatic activities for ceramide metabolism in cells.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>21127389</pmid><doi>10.1254/jphs.10181FP</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-8613
ispartof Journal of Pharmacological Sciences, 2010, Vol.114(4), pp.420-432
issn 1347-8613
1347-8648
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1750bccab989434593a4ff4bd6cc1f3e
source ScienceDirect
subjects A549 and Chinese hamster ovary (CHO) cells
Animals
Cells, Cultured
ceramidase
Ceramidases - physiology
ceramide kinase
ceramide-1-phosphate
Ceramides - analysis
Ceramides - metabolism
CHO Cells - metabolism
Chromatography, Thin Layer - methods
Cricetinae
Cricetulus
Humans
Phosphorylation
Phosphotransferases (Alcohol Group Acceptor) - physiology
Protein-Tyrosine Kinases - physiology
Sphingosine - analysis
Stimulation, Chemical
Tumor Cells, Cultured
vanadate
Vanadates - pharmacology
title Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A55%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20Ceramidase%20and%20Ceramide%20Kinase%20by%20Vanadate%20via%20a%20Tyrosine%20Kinase%E2%80%93Mediated%20Pathway&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Tada,%20Eiko&rft.aucorp=Department%20of%20Health%20Science&rft.date=2010&rft.volume=114&rft.issue=4&rft.spage=420&rft.epage=432&rft.pages=420-432&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.10181FP&rft_dat=%3Cproquest_doaj_%3E818642591%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c782t-5b0c4386193694406453029b54aa8dd18a6ac087095c33c90efdbec1af57afb03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=818642591&rft_id=info:pmid/21127389&rfr_iscdi=true